- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
INOVOTION
INOVOTION is listed as a new startup research supplier in the Scientist.com network, with 4 sites in 2 countries.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: New startup
Biomarkers
- Histopathology Evaluate slide preparation of cells or tissues for abnormal features.
Cell Culture and Characterization
- Histology Examine by microscopy the anatomy of cells and tissues of clinical patients and animal models.
Oncology Models
- Angiogenesis Models Measure therapeutic endpoints in animal models of angiogenesis.
- Oncology Models Use model organisms to test the therapeutic efficacy of cancer drug candidates.
- Renal Xenograft Measure therapeutic endpoints in renal models of cancer.
- Xenograft Models Measure therapeutic endpoints in cancer models using tumor cells transplanted from a donor of a different species.
Where it operates
Sites by country, with the cities in each.
-
France 3 sites
-
United States 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to oncology efficacy and toxicity assay. Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage. This breaking-thought technology, based on chick embryo, provides early analysis of your drug candidates. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities. This next generation...
Show the full description
INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to oncology efficacy and toxicity assay.
Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage.
This breaking-thought technology, based on chick embryo, provides early analysis of your drug candidates. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities.
This next generation of in vivo efficacy and toxicity tests covers fours main aspects:
- EFFICACY assays for your anti-cancer treatments
- EARLY TOXICITY assays for your drug candidates
- TARGET VALIDATION in oncology
- MULTI-CANCER SCREENING to (re)positioning your treatment
Thanks to this approach, we open really news perspectives of screening for chemists and biologists in public and private sector (biotech and pharma companies)
- Website
- www.inovotion.com
Work with INOVOTION on Scientist.com
For prices, more details, or to contact INOVOTION, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.